This product is currently not available for purchase.


Building a Better Infectious Disease Surveillance System for China. Edition No. 1

  • ID: 1908397
  • September 2009
  • Region: China
  • 96 Pages
  • VDM Publishing House
1 of 3

The sudden outbreak of SARS in 2003 exposed many weaknesses of China’s national disease reporting system and consequently leads to the establishment of National Infectious Disease Monitoring Information System. Although the new system provides timely and live reports of infectious diseases, miss-diagnosis and under-reporting often undermine the quality of the reported data. Disease information flow largely remains one-way through the system’s information hierarchy and its disclosure and feedback remains strictly restricted. Structural attachment of CDCs on all levels of government compromises its independency and administrative efficiency, which leads to lack of incentive and accountability for reporting, fragmentation of surveillance and difficulties of data sharing. Reformation that separates China CDC as an independent research institution may significantly increase its functionality and capability for IDs surveillance, but sustainable improvements in surveillance performance relies on a greater reform in the overall healthcare system. The author recommends this book to public health policy makers in China and those who endeavor to create a healthier life for the Chinese people.

Note: Product cover images may vary from those shown
2 of 3

Lei, Zhang.
Dr. Lei Zhang: BSc and MSc at the University of Sydney. PhD in University of New South Wales, Australia. MPH in University of Applied Science, Hamburg. Research at Bar Ilan University, Israel and Institute of Theoretical Biology, Humboldt University, Berlin. Current lecturer in National Centre in HIV Epidemiology and Clinical Research, Australia.

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown


If you have a more general question about our products please try our


Our Clients

  • AB Sciex
  • Eli Lilly and Company
  • B. Braun Melsungen AG
  • Astellas Pharma, Inc.
  • Hologic Corporation
  • Merck & Co., Inc.